Physician profile
Thomas C Wisler
NPI 1437140449
$2,162.34
in general payments reported to CMS, 2019-2025
29 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $349 · 2020: $79.32 · 2021: $644 · 2022: $549 · 2023: $258 · 2024: $165 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $541.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $541.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $433.51 | 2019-2023 | Orilissa |
| Evofem Biosciences, INC. | $164.99 | 2021-2022 | |
| Myovant Sciences INC. | $149.22 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $145.87 | 2023-2024 | Myfembree |
| Aspira Women'S Health INC | $143.16 | 2022 | |
| Coopersurgical, INC. | $123.53 | 2021 | |
| Pfizer INC. | $107.60 | 2022-2024 | |
| Exeltis, USA INC. | $107.13 | 2021-2025 | Slynd |
| Mayne Pharma Commercial LLC | $101.60 | 2022-2025 | |
| Alydia Health | $78.60 | 2021 | |
| Hologic Sales and Service, LLC | $50.67 | 2019-2024 | Omni Hysteroscope, Novasure |
| Scynexis, INC. | $48.17 | 2022 | |
| Merck Sharp & Dohme LLC | $43.82 | 2019-2024 | Gardasil 9, Gardasil |
| Organon LLC | $43.78 | 2022-2024 | |
| Biogen, INC. | $42.50 | 2025 | Zurzuvae |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $41.89 | 2021-2022 | |
| Minerva Surgical, INC | $40.08 | 2019-2023 | |
| Astellas Pharma US INC | $36.33 | 2023-2025 | Veozah, Myrbetriq |
| Smith+Nephew, INC. | $36.26 | 2019 | |
| Exact Sciences Corporation | $33.61 | 2023 | Cologuard Collection Kit |
| Medtronic, INC. | $30.02 | 2022 | |
| Duchesnay USA Incorporated | $28.19 | 2019 | |
| Agile Therapeutics, INC. | $28.15 | 2021 | |
| Amgen INC. | $22.26 | 2021 | |
| Medicem INC. | $19.75 | 2023 | |
| Millicent US INC | $17.77 | 2024 | Intrarosa |
| Amag Pharmaceuticals, INC. | $15.87 | 2020 | |
| Meditrina | $15.52 | 2022 | |
| Avion Pharmaceuticals | $12.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Wisler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.